Short summary
Genetech: engineered DNA in foreig cells
Long summary
Genentech was also a disruptive company (now belonging to Roche). They disrupted the pharmaceutical landscape by introducing new biotechnology, e.g., cloning genetically engineered DNA in foreign cells and mass-producing the resulting drugs.
Citation
Leuty, Ron. “40 Years After Genentech Set Biotech Industry Standards, Is It Still Disruptive–Or Disrupted?” San Francisco Business Times, May 20, 2016.
Source
Article
file
tag
Article